Selvita S.A.
Records under this name other than the patents Selvita S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Selvita S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,388,192 | Benzimidazole derivatives as Kinase Inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,174,013 | Benzimidazole derivatives as kinase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,212,200 | Handling Audio Path Failure and Poor Quality of Service for Voice Calls in a Contact Center Formerly held In force · High confidence | In force | High confidence | |
| US 10,577,365 | Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,604,217 | Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent Lapsed on the fee record Ended Dec 10, 2017 · USPTO record | Lapsed on the fee record | Ended Dec 10, 2017 | USPTO record |
| US 7,528,259 | Derivatives of 4,5,6,7-tetrabromobenzimidazole and method of their preparation Lapsed on the fee record Ended May 5, 2017 · USPTO record | Lapsed on the fee record | Ended May 5, 2017 | USPTO record |